BFA
ANAC

BlackRock Fund Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

BlackRock Fund Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,783,935
Closed -$95.4M – 4428
2016
Q1 		$95.4M Buy
1,783,935
+68,139
+4% +$5.03M 0.02% 991
2015
Q4 		$194M Sell
1,715,796
-81,380
-5% -$8.97M 0.04% 505
2015
Q3 		$212M Sell
1,797,176
-41,733
-2% -$5.45M 0.05% 399
2015
Q2 		$142M Buy
1,838,909
+87,192
+5% +$5.72M 0.03% 708
2015
Q1 		$101M Sell
1,751,717
-1,265
-0.1% -$53.7K 0.02% 993
2014
Q4 		$56.5M Buy
1,752,982
+126,724
+8% +$3.8M 0.01% 1378
2014
Q3 		$39.8M Buy
1,626,258
+322,023
+25% +$6.54M 0.01% 1505
2014
Q2 		$23.1M Buy
1,304,235
+100,054
+8% +$1.61M 0.01% 1933
2014
Q1 		$24.1M Buy
1,204,181
+51,251
+4% +$994K 0.01% 1898
2013
Q4 		$19.3M Sell
1,152,930
-3,392
-0.3% -$46.9K 0.01% 2007
2013
Q3 		$12.3M Buy
1,156,322
+151,601
+15% +$1.33M ﹤0.01% 2231
2013
Q2 		$5.62M Buy
+1,004,721
New +$6.08M ﹤0.01% 2614

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

BlackRock Fund Advisors's ANAC Position: Q2 2016 in Review

BlackRock Fund Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 1,783,935 shares — an estimated $95.4M sold.

BlackRock Fund Advisors first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $212M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • BlackRock Fund Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • BlackRock Fund Advisors sold 1,783,935 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $95.4M.
  • BlackRock Fund Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • BlackRock Fund Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $212M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on BlackRock Fund Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.